Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are patients at the University of Miami Pediatric Endocrinology Clinic
- People who have been diagnosed with obesity (a body mass index at or above the 95th percentile for their age) and Type 2 Diabetes (a blood sugar measurement known as Hemoglobin A1c above 6.5%)
- Children and teenagers between the ages of 5 and 18
- Young adults between the ages of 19 and 21
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have conditions that prevent them from doing physical activity or exercise
- People who do not have a television at home
- People who are pregnant
- People who are currently in juvenile detention or prison
- Adults who are not able to give their own legal consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Patricia Gomez, M.D., University of Miami
Phone: 305-243-2920
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent Weight Change; Change in HbA1c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.